INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES. RMSR [Internet]. 2025 Apr. 14 [cited 2025 Apr. 30];3(4):307-12. Available from: http://www.thermsr.com/index.php/Journal/article/view/929